Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Exercise shown to have some AFib-specific benefits.
Read More »JUST 30 MINUTES : Dramatic Decrease in AF With Cardio Fitness
The Safest First-Line Therapy for Type 2 Diabetes
According to more than 200 studies involving 1.4 million patients, metformin reduces heart disease risk in diabetes patients more effectively than its competitors.
Read More »New GLP-1 Drug Shows Cardiovascular Benefit
This is the fourth drug to treat diabetes that also can reduce the risk of heart disease.
Read More »Januvia for High Risk CVD Patients is Safe
A secondary analysis of the TECOS trial affirms sitagliptin does not increase heart failure risk for patients with type 2 diabetes.
Read More »Stenting Risks For Insulin-Treated Diabetes Patients
Insulin may not be the culprit in poorer outcomes, according to TUXEDO sub-study.
Read More »SBP Level May Be Key to Setting Blood Pressure Treatment Goals for Diabetes
New meta analysis suggests overly aggressive goals may increase cardio risk for patients with systolic blood pressure below 140 mm Hg.
Read More »Can a Common Diabetes Drug Help Heart Attack Recovery?
Better understanding of drug’s mechanism of action can lead the way to new treatment options for heart disease in diabetes patients.
Read More »Severe Hypoglycemia in Type 2 Diabetes Linked to Progression of Coronary Artery Disease
Patients treated with standard therapy for blood glucose control show link between serious hypoglycemia and CAC progression, increasing risk of heart attack and stroke.
Read More »Bromocriptine-QR for Prevention of Cardiovascular Events in Type 2 Diabetes
Bromocriptine-QR may reduce CVD risk in type 2 patients independent of its effect on glycemic control.
Read More »How Low is Too Low? Blood Pressure Goals for Diabetic Patients
Research indicates setting more aggressive blood pressure goals for diabetic patients may cause harm.
Read More »